Contact us

Turner is a North America-based, international construction services company and is a leading builder in diverse market segments.

Get to know us

Our people bring their technical knowledge, experience, and resourcefulness to the delivery of our construction services. Our expertise and value-added offerings support our clients throughout the lifespan of the construction process.

As the largest general contractor in the country, Turner is a leader in all major market segments, including healthcare, education, commercial, sports, aviation, pharmaceutical, retail and green building.

See Our Portfolio

Stay up to date with the latest news and insights from Turner. Learn from our industry experts sharing innovation, market insight and thought leadership.

Browse Insights

An awarding and fulfilling career awaits you at Turner! Join our team and build some of the most exciting and innovative projects around the world.

Explore careers at Turner
Four Seasons Modernization

Four Seasons Modernization

Contact us

Additional Information

Thanks for your interest in Turner. Whether you are looking to start a project, get support, or just have a general question, we want to hear from you. Drop us a line and we will get back to you.

Turner Construction Company

66 Hudson Boulevard East

New York, NY 10001

(212) 229-6000

Report issues 24 hours a day, 7 days a week to Turner’s Confidential Reporting System

(888) 738-1924

Before reaching out, please review our prequalification requirements.

Become a Subcontractor

Agilent Technologies Selects Turner to Build $725 Million Pharmaceutical Manufacturing Plant in Fred

Agilent Technologies Selects Turner to Build $725 Million Pharmaceutical Manufacturing Plant in Fred

Denver, Colorado, February 9, 2023 – Turner Construction Company is pleased to announce that Agilent Technologies selected the company to build a $725 million facility to produce active pharmaceutical ingredients (API) in Frederick, Colorado.

The 200,000 square foot project increases Agilent’s capacity to meet demand for the company’s synthetic oligonucleotides, which help treat cancer, cardiovascular disease, and other rare diseases. The project will be built in accordance with Process Safety Management (PSM) standards.

“It is great to be part of project that will improve the care available for people that are facing a wide range of healthcare challenges,” said Scott Bustos, Vice President and General Manager of Turner Construction Company. Scott continued, “I thank Agilent for their trust in the technical expertise of our people and for their investment in the Frederick, Colorado, community that will have such a broad and positive impact on society.”

The project is scheduled for completion in 2026.